O'Hara Paul, Alzayer Husam, Harris Luke, Gorey David, McMonagle Edward, Madden Michelle, Elhassan Elhussien, Reddan Donal, Casserly Liam, Leavey Sean, Conlon Peter
Department of Nephrology, Galway University Hospitals, Galway, Ireland.
Department of Nephrology, Beaumont Hospital, Dublin, Ireland.
Ir J Med Sci. 2024 Dec;193(6):3053-3058. doi: 10.1007/s11845-024-03769-4. Epub 2024 Aug 1.
The occurrence of Kidney Failure with Replacement Therapy (KFRT) amongst Irish Travellers has not been well described. This study aims to determine the burden of KFRT amongst the Irish Traveller population and identify determinants of health amongst this cohort which may differ from the general population in Ireland.
This retrospective cohort study included self-identifying Irish Travellers with KFRT registered in the National Kidney Disease Clinical Patient Management System between 1995 and 2022. KFRT was defined as Chronic Kidney Disease stage 5 (CKD G5) treated by dialysis or CKD G1-G5 after transplantation. The primary outcome measure was the prevalence of KFRT in Irish Travellers. Secondary exploratory outcomes included age at diagnosis, family history, biopsy diagnosis, kidney replacement therapy (KRT) modality, time to initiation of KRT, primary vascular access used, and time to receive a kidney transplant.
Four of six Irish hospital groups participated in the study. A total of 38 patients were identified as Irish Travellers with KFRT, with a crude prevalence rate of KFRT of 0.12% (CI 0.084-0.161, 95%) or 11.9 per 10,000 Irish Travellers. The mean age for diagnosis of kidney disease was 43 (SD, 20.8) and at commencement of KRT was 45 (SD, 20.9) years. A biopsy-proven diagnosis was provided in 24%. Twenty-two per cent was diagnosed with polycystic kidney disease or congenital anomalies of the kidney and urinary tract. The predominant modality for KRT was haemodialysis (89%), with central venous catheters being the most common initial vascular access (79%). Kidney transplants occurred in 45% of those studied, with a mean waiting time of 1.96 (SD, 1.6) years.
The Irish Traveller community have similar prevalence of KFRT when compared to the national prevalence, with a short time interval from diagnosis to commencement of KRT. They are less likely to avail of home therapies but have comparable wait times to the national waiting time to receive a kidney transplant.
爱尔兰游民中接受肾脏替代治疗(KFRT)的情况尚未得到充分描述。本研究旨在确定爱尔兰游民群体中KFRT的负担,并确定该队列中可能与爱尔兰普通人群不同的健康决定因素。
这项回顾性队列研究纳入了1995年至2022年期间在国家肾脏疾病临床患者管理系统中登记的自我认定为患有KFRT的爱尔兰游民。KFRT被定义为接受透析治疗的慢性肾脏病5期(CKD G5)或移植后的CKD G1 - G5。主要结局指标是爱尔兰游民中KFRT的患病率。次要探索性结局包括诊断年龄、家族史、活检诊断、肾脏替代治疗(KRT)方式、开始KRT的时间、使用的主要血管通路以及接受肾脏移植的时间。
六个爱尔兰医院组中有四个参与了该研究。共有38名患者被确定为患有KFRT的爱尔兰游民,KFRT的粗患病率为0.12%(CI 0.084 - 0.161,95%),即每10000名爱尔兰游民中有11.9人患病。肾病诊断的平均年龄为43岁(标准差,20.8),开始KRT时的平均年龄为45岁(标准差,20.9)。24%的患者有活检证实的诊断。22%的患者被诊断为多囊肾病或肾脏和尿路先天性异常。KRT的主要方式是血液透析(89%),中心静脉导管是最常见的初始血管通路(79%)。45%的研究对象接受了肾脏移植,平均等待时间为1.96年(标准差,1.6)。
与全国患病率相比,爱尔兰游民群体中KFRT的患病率相似,从诊断到开始KRT的时间间隔较短。他们较少采用家庭治疗,但接受肾脏移植的等待时间与全国等待时间相当。